Condition
Pathological Complete Response clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Pathological Complete Response clinical trials that are recruiting, at sites in 3 countries (most in China (2), Italy (1), Taiwan (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Pathological Complete Response clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using AI on CT scans to predict complete response in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy | — | Wuhan, Hubei | Recruiting | Jul 28, 2025 |
| Neoadjuvant immunochemotherapy and chemoradiotherapy before surgery for advanced esophageal squamous cell carcinoma | Phase 2 | Taipei | Recruiting | Jan 8, 2025 |
| Omitting axillary surgery in breast cancer patients with complete response after treatment | — | Nanjing | Recruiting | Jul 11, 2023 |
| Adaptive MRI-guided Radiotherapy in Rectal Cancer to See If High Dose Helps Some Patients | — | Roma, Roma | Recruiting | Mar 25, 2021 |
All recruiting trials (4)
-
Using AI on CT scans to predict complete response in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
This project will test whether a deep-learning model using chest CT images and clinical data can predict which esophageal squamous cell carcinoma patients will have a complete pathological response after neoadjuvant immunochemotherapy.
-
Neoadjuvant immunochemotherapy and chemoradiotherapy before surgery for advanced esophageal squamous cell carcinoma
This study tests whether giving the immune drug tislelizumab with chemotherapy before and then combining chemoradiotherapy, followed by surgery, helps people with locally advanced esophageal squamous cell carcinoma.
-
Omitting axillary surgery in breast cancer patients with complete response after treatment
This study is testing if women with breast cancer who have no signs of cancer in their lymph nodes after treatment can safely skip surgery to remove those lymph nodes.
-
Adaptive MRI-guided Radiotherapy in Rectal Cancer to See If High Dose Helps Some Patients
This trial tests whether increasing radiation dose during treatment helps rectal cancer patients who show poorer early response on MRI-guided therapy.
Related topics
Quick answers
How many Pathological Complete Response clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Italy (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.